Human Allograft Tissue
Human Regenerative Medicine Therapy (HAF) has been used for centuries in the treatment of different maladies and conditions. HAF has been shown to be a mixology of beneficial collagens, cytokines, elastins and growth factors that can proliferate the treatment, healing and regenerative qualities of the human body. The presence of extracellular matrices can help to provide a natural scaffold that may accelerate healing while potentially reducing the incidence of inflammation and scarring.
Human Regenerative Medicine Therapy is said to be immune privileged, rarely inducing a resistant reaction to the recipient. The presence of multiple growth factors such as, VEG, TGFB1, TGFB3 and GDF11 (also called GD11, BMP11, and GDF-11) can promote cell growth and regeneration of healthy collagens I, II, III, IV, V and VI that help proliferate healing.
Donated human Regenerative Medicine Therapy used in the clinic or hospital comes from an American Academy of Tissue Banks (AATB) accredited tissue bank only. Further, Regenerative Medicine Therapy derived Regenerative Medicine Therapy and growth factors are regulated through the FDA Center for Biologics Evaluation and Research (CBER) which regulates HCT/Ps under 21 CFR Parts 1270 and 21 CFR Part 1271 and Section 361 of the Public Health Service Act
PRP (Platelet Rich Plasma)
Many patients are familiar with professional athletes to undergo PRP treatments in the off-season to recover from chronic wear and tear injuries. Fortunately, costs have come down and can often be performed in the clinic or at the hospital. The process is rather simple, and nurse will draw your blood, spin it down in a centrifuge, then extract the platelets and inject them in your injury area. Platelets are known for clotting blood, but they also release powerful growth factors that play a role in healing. This is a similar concept as regenerative medicine with the Regenerative Medicine Therapy.
Regenerative Medicine Therapy
A Regenerative Medicine Therapy is essentially the building block of the human body. Regenerative Medicine Therapy are capable of dividing for long periods of time, are unspecialized, but can develop into specialized cells. FDA approved sources include bone marrow, fat cells, and Regenerative Medicine Therapy. The Regenerative Medicine Therapy inside an embryo will eventually give rise to every cell, tissue and organ in the fetus’s body. Unlike a regular cell, which can only replicate to create more of its own kind of cell, a Regenerative Medicine Therapy is pluripotent. When it divides, it can make any one of the 220 different cells in the human body. Regenerative Medicine Therapy also have the capability to self-renew — they can reproduce themselves many times over.
There is extensive research regarding the use of bone marrow obtained Regenerative Medicine Therapy (mesenchymal Regenerative Medicine Therapy or MSC’s) and growing research in the field of amniotic sourced Regenerative Medicine Therapy and growth factors. Dr. Nash is one of the pioneers in the field of implementing amniotic sourced Regenerative Medicine Therapy and growth factor treatments, with nearly four years of experience and more than 2000 injections to date. Dr. Nash has collaborated with major regenerative companies to develop protocols and further research.
Controversial or not?
When the topic of ‘Regenerative Medicine Therapy’ comes up, it can be a tense subject. Fortunately, there is no moral/ethical issue when you research the source and techniques. The human allograft tissue, which may contain frozen (cryopreserved) Regenerative Medicine Therapy and growth factors, ONLY comes from elective C-sections.
Tissue labs accredited by the American Academy of Tissue Banks only accept elective C-section obtained Regenerative Medicine Therapy and tissue. These are NOT the product of abortion or unwanted embryos obtained from fertility clinics or other sources.
Growth factors are naturally occurring regulatory molecules, which bind to receptors on the cell surface. They stimulate cell and tissue function through influencing cell differentiation by changing their biochemical activity and cellular growth, and regulating their rate of proliferation. Numerous families of growth factors have already been identified and remarkable advancements have been made in understanding the pathways growth factors use to activate cellular proliferation and differentiation.
Growth factors can recruit your bodies natural repair and healing cells, including new cartilage creation and blood vessel growth. Exciting new research shows that some growth factors recruit your own circulating Regenerative Medicine Therapy to the target site of injury.
While the following articles are quite technical, the background and conclusions include the broad concepts and goals of treatment of familiar musculoskeletal conditions.
1) Amniotic tissue acting as a ‘Regenerative Medicine Therapy magnet’ to recruit Regenerative Medicine Therapy to the site of injection/implantation.
2) Exciting new applications of combination umbilical cord and amniotic membrane preparations, made by Amniox
Clarix products can help improve foot and ankle outcomes
3) Dehydrated Human Amnion/Chorion Membrane allografts as a therapy for orthopedic tissue repair – in cases of plantar fasciitis, tendinopathy, and veterbral fusion treatments.
4) Study demonstrates the benefit of combining amnion and chorion to increase the number of growth factors delivered to the action site, whether a wound or injured tissue.
5) For those of you that want to dive deeper, this is a good overview that explains how amnion/chorion tissue helps to activate the growth factors as the key to tissue healing.